This book is a valuable resource for health professionals, researchers, health practitioners, graduate and medical students, and anyone who wishes to broaden their knowledge in the allied ?eld.
Table of Contents
1. Epidemiology of breast cancer2. Risk factors for breast cancer: knowledge and prevention
3. Histological and molecular classification of breast cancer: Basic understanding
4. Breast cancer stromal and its components: implication in diagnostic and therapeutic
5. Genetic behind breast cancer: Germline and somatic factors
6. Heterogeneity of breast cancer: a major cause of therapy failure
7. Recent advancement in molecular tools for breast cancer diagnosis and trends in future perspective
8. Recent development in treatment strategies for breast cancer: With special reference to immunotherapy
9. Liquid biopsy: A non-invasive tool in breast cancer diagnosis
10. Protein biomarkers in breast cancer: Implication in diagnosis and prognosis
11. Understanding of therapeutic resistance: With special resistance to breast cancer
12. Breast Cancer Stem Cell: Role in Carcinogenesis
13. Plant derived biomolecules: role in breast cancer initiation and progression
Authors
Dharambir Kashyap Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA..Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91
Riya Sharma Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals.
Vivek Kumar Garg Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali, Punjab, India.Dr. Garg is currently an Associate Professor at Chandigarh University in India. In 2018, he earned his PhD in Neurology and holds his M.Sc. in Medical Biochemistry. He has published 47 articles in prestigious journals and 12 book chapters. He is also a reviewer and editorial board member of 12 PubMed/Scopus-indexed journals.
Huda Salman Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.Dr. Salman is Director of the Brown Center for Immunotherapy, Co-leader of the HHM CC Program, Don Brown Professor of Immunotherapy, and Professor of the Department of Medicine, Microbiology and Immunology, Indiana University, Indianapolis, IN 46202. She holds the MD and PhD in Medicine. She is on the editorial board of several journals with a high impact factor. She is mentioned as America's most honored doctor (2020-2022). She has published several articles. Her expertise is in the engineering and manufacturing Chimeric Antigen Receptor T-cells (CAR-T cells) for treating hematological malignancies and solid tumors.
